Bronchodilators are used internationally for 50–80% of patient swith cystic fibrosis (CF). No published data exists on co-morbid asthma or bronchodilator use in New Zealand (NZ). Bronchodilator responsiveness has been reported in≥50% of patients with CF. Aim: To determine the prevalence of co-morbid asthma in the adult CF population of Wellington, NZ.
|Publication status||Published - 2015|
|Event||Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science Annual Scientific Meeting 2015 - Gold Coast, Australia|
Duration: 27 Mar 2015 → 01 Apr 2015
|Conference||Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science Annual Scientific Meeting 2015|
|Period||27/03/15 → 01/04/15|